Form 4 for LH Labcorp
Accepted 2022-08-05 00:00:00 ET · period of report 2022-08-03 · accession 0001127602-22-020514 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-05 | 2022-08-03 | LH | EISENBERG GLENN A | CFO, EVP | S - Sale+OE | $253.94 | -32.1K | 53.7K | -37% | -$8.15M |
| DM | 2022-08-05 | 2022-08-03 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | $147.12 | +32.1K | 63.6K | +102% | +$4.72M |
| DM | 2022-08-05 | 2022-08-03 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | $0.00 | -32.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-03 | S | D | 1,500 | $254.88 | 52,158 | D | — | — | (F3) The price of $254.879 per share represents a weighted average of sales prices ranging from $254.75 to $255.02 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2022-08-03 | M | A | 11,600 | $146.59 | 84,258 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-03 | M | A | 9,100 | $168.49 | 72,658 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-03 | M | A | 11,400 | $130.60 | 63,558 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-03 | S | D | 11,262 | $253.27 | 72,996 | D | — | — | (F1) The price of $253.265 per share represents a weighted average of sales prices ranging from $252.71 to $253.70 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| 6 | Common | Common Stock | 2022-08-03 | S | D | 19,338 | $254.26 | 53,658 | D | — | — | (F2) The price of $254.259 per share represents a weighted average of sales prices ranging from $253.71 to $254.71 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| 7 | Derivative | Non-qualified Stock Options | 2022-08-03 | M | D | 11,400 | $0.00 | 0 | D | $130.60 · 2018-02-07 to 2027-02-06 | 11,400 Common Stock | (F4) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F5) The option vested in three equal annual installments beginning on the date reflected in this column. |
| 8 | Derivative | Non-qualified Stock Options | 2022-08-03 | M | D | 11,600 | $0.00 | 0 | D | $146.59 · 2020-02-12 to 2029-02-11 | 11,600 Common Stock | (F4) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F5) The option vested in three equal annual installments beginning on the date reflected in this column. |
| 9 | Derivative | Non-qualified Stock Options | 2022-08-03 | M | D | 9,100 | $0.00 | 0 | D | $168.49 · 2019-02-12 to 2028-02-11 | 9,100 Common Stock | (F4) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F5) The option vested in three equal annual installments beginning on the date reflected in this column. |